venBio Global Strategic Fund II L.P. [Rocket]

Date Filed	Type	Description
09/15/2022	SC 13D/A	venBio Global Strategic Fund II L.P. reports a 1.9% stake in Akero Therapeutics, Inc.
06/07/2022	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/05/2022	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022	SC 13G/A	venBio Global Strategic Fund II L.P. reports a 4.7% stake in Harmony Biosciences Holdings, Inc.
05/07/2021	SC 13D/A	venBio Global Strategic Fund II L.P. reports a 6.6% stake in Akero Therapeutics, Inc.
05/07/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021	SC 13G	venBio Global Strategic Fund II L.P. reports a 6.2% stake in Harmony Biosciences Holdings, Inc.
10/06/2020	SC 13G	venBio Global Strategic Fund II L.P. reports a 17.1% stake in Checkmate Pharmaceuticals, Inc.
10/01/2020	SC 13D	venBio Global Strategic Fund II L.P. reports a 26.9% stake in ALX ONCOLOGY HOLDINGS INC.
09/09/2020	SC 13D/A	venBio Global Strategic Fund II L.P. reports a 7.7% stake in Akero Therapeutics, Inc.
04/16/2020	SC 13D/A	venBio Global Strategic Fund II L.P. reports a 0% stake in Menlo Therapeutics Inc.
01/15/2020	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/26/2019	SC 13D	venBio Global Strategic Fund II L.P. reports a 14.2% stake in Akero Therapeutics, Inc.
02/14/2019	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2018	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2018	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2018	SC 13D	venBio Global Strategic Fund II L.P. reports a 6.4% stake in Menlo Therapeutics Inc.
05/08/2017	SC 13G	Verona Pharma plc reports a 7.1% stake in Verona Pharma plc
02/13/2017	SC 13G/A	Nabriva Therapeutics AG reports a 8.2% stake in Nabriva Therapeutics AG
04/29/2016	SC 13G	Nabriva Therapeutics AG reports a 5.6% stake in Nabriva Therapeutics AG